Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Morskaya SS"'
Autor:
David Anz, Simon Rothenfusser, J. Landsberg, Gunther Hartmann, Morskaya Ss, Cornelius Maihoefer, Evelyn Gaffal, Shizuo Akira, Ulrich Kalinke, Carola Berking, Michael Bscheider, Marcel Renn, Marco Prinz, Georg Häcker, Robert Besch, Hiroki Kato, Elisabeth Kremmer, Tobias Schwerd, Johannes C. Hellmuth, Alexandra Schmidt, Damia Tormo, Hendrik Poeck, Hornung, Thomas Tüting, Susanne Kirschnek, Rachel Meyers, Stefan Endres, Dirk H. Busch, Carole Bourquin, Jürgen Ruland, Michael Neuenhahn
Publikováno v:
Nature Medicine. 14:1256-1263
Genetic and epigenetic plasticity allows tumors to evade single-targeted treatments. Here we direct Bcl2-specific short interfering RNA (siRNA) with 5'-triphosphate ends (3p-siRNA) against melanoma. Recognition of 5'-triphosphate by the cytosolic ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45d3872c74b7bd1ce451bf9eb4dfa27
https://doi.org/10.1038/nm.1887
https://doi.org/10.1038/nm.1887
Autor:
Anglero-Rodriguez YI; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Lempp FA; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Subramanian M; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., McIninch J; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Schlegel MK; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Bohan D; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Wong E; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Brown CR; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Foster DJ; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Castoreno AB; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Nguyen T; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Cuffe D; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Montiel-Ruiz M; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Kaiser H; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Sahakyan A; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Spreafico R; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Morskaya SS; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Barry JD; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Berman D; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Zhang L; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Lefebvre S; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Kasper A; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Racie T; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Weddle D; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Mobley M; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Wassarman K; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Bisbe A; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Zlatev I; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Rogers A; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Nechev L; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Dybowski J; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Chong S; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Nair J; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Simon A; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Sloan K; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Hwang S; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Virgin HW; Vir Biotechnology Inc.; San Francisco, CA 94158, USA.; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA., Fitzgerald K; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Maier MA; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Hinkle G; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Hebner CM; Vir Biotechnology Inc.; San Francisco, CA 94158, USA., Akinc A; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA., Jadhav V; Alnylam Pharmaceuticals; Cambridge, MA 002142, USA.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.
Autor:
Nakayama T; Alnylam Pharmaceuticals, Inc., Cambridge, MA 02142, USA. tnakayama@verizon.net, Butler JS, Sehgal A, Severgnini M, Racie T, Sharman J, Ding F, Morskaya SS, Brodsky J, Tchangov L, Kosovrasti V, Meys M, Nechev L, Wang G, Peng CG, Fang Y, Maier M, Rajeev KG, Li R, Hettinger J, Barros S, Clausen V, Zhang X, Wang Q, Hutabarat R, Dokholyan NV, Wolfrum C, Manoharan M, Kotelianski V, Stoffel M, Sah DW
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2012 Aug; Vol. 20 (8), pp. 1582-9. Date of Electronic Publication: 2012 Jun 05.
Autor:
Alvarez R; Alnylam Pharmaceuticals, 300 Third Street, Cambridge, MA 02142, USA., Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, Van Ranst M, Tripp RA, DeVincenzo JP, Pandey R, Maier M, Nechev L, Manoharan M, Kotelianski V, Meyers R
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2009 Sep; Vol. 53 (9), pp. 3952-62. Date of Electronic Publication: 2009 Jun 08.
Autor:
Poeck H; Institute of Clinical Chemistry and Pharmacology, University Hospital, University of Bonn, Bonn, Germany., Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, Kirschnek S, Gaffal E, Landsberg J, Hellmuth J, Schmidt A, Anz D, Bscheider M, Schwerd T, Berking C, Bourquin C, Kalinke U, Kremmer E, Kato H, Akira S, Meyers R, Häcker G, Neuenhahn M, Busch D, Ruland J, Rothenfusser S, Prinz M, Hornung V, Endres S, Tüting T, Hartmann G
Publikováno v:
Nature medicine [Nat Med] 2008 Nov; Vol. 14 (11), pp. 1256-63. Date of Electronic Publication: 2008 Nov 02.